L. M. Ørnbjerg Et Al. , "Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care," The Journal of rheumatology , vol.51, no.4, pp.378-389, 2024
Ørnbjerg, L. M. Et Al. 2024. Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care. The Journal of rheumatology , vol.51, no.4 , 378-389.
Ørnbjerg, L. M., Rugbjerg, K., Georgiadis, S., Rasmussen, S. H., Jacobsson, L., Loft, A. G., ... Iannone, F.(2024). Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care. The Journal of rheumatology , vol.51, no.4, 378-389.
Ørnbjerg, Lykke Et Al. "Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care," The Journal of rheumatology , vol.51, no.4, 378-389, 2024
Ørnbjerg, Lykke M. Et Al. "Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care." The Journal of rheumatology , vol.51, no.4, pp.378-389, 2024
Ørnbjerg, L. M. Et Al. (2024) . "Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care." The Journal of rheumatology , vol.51, no.4, pp.378-389.
@article{article, author={Lykke M. Ørnbjerg Et Al. }, title={Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care}, journal={The Journal of rheumatology}, year=2024, pages={378-389} }